 | • レポートコード：QYR9ST05032 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、皮膚がん治療薬の世界市場について調査・分析し、皮膚がん治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、放射線療法、凍結手術、免疫療法、光線力学療法、手術、その他の治療）、用途別（病院、クリニック、がん研究センター、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の皮膚がん治療薬市場動向 ・主要企業別マーケットシェア ・皮膚がん治療薬の種類別市場規模2014-2019 （化学療法、放射線療法、凍結手術、免疫療法、光線力学療法、手術、その他の治療） ・皮膚がん治療薬の用途別市場規模2014-2019 （病院、クリニック、がん研究センター、その他） ・皮膚がん治療薬の北米市場：主要企業・種類別/用途別市場規模 ・皮膚がん治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・皮膚がん治療薬の中国市場：主要企業・種類別/用途別市場規模 ・皮膚がん治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・皮膚がん治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・皮膚がん治療薬のインド市場：主要企業・種類別/用途別市場規模 ・皮膚がん治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer、Merck、Novartis、GlaxoSmithKline、Bristol Myers Squibb、Eli Lilly、Roche、Qiagen、Boehringer Ingelheim、Aqua Pharmaceuticals、Meda、Elekta AB、Varian Medical Systems、Valeant Pharmaceuticals） ・皮膚がん治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
On the basis of the type of tissue affected, there are three major types of skin cancer, namely, basal cell carcinoma, squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the extension of current therapies are fueling the growth of the market. However, high cost associated with therapy, a stringent regulatory environment, and the lack of awareness in the general population could adversely affect market growth.In 2017, North America was the largest regional market, in terms of revenue.
The Asia-Pacific region is expected to grow at a rapid pace over the forecast period, owing to increasing healthcare expenditure and government initiatives aimed at increasing awareness in the developing economies of the region.
In 2018, the global Skin Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Skin Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Skin Cancer Therapeutics development in United States, Europe and China.
The key players covered in this study
Pfizer
Merck
Novartis
GlaxoSmithKline
Bristol Myers Squibb
Eli Lilly
Roche
Qiagen
Boehringer Ingelheim
Aqua Pharmaceuticals
Meda
Elekta AB
Varian Medical Systems
Valeant Pharmaceuticals
Market segment by Type, the product can be split into
Chemotherapy
Radiotherapy
Cryosurgery
Immune Therapy
Photodynamic Therapy
Surgery
Other Treatments
Market segment by Application, split into
Hospital
Clinic
Cancer Research Center
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Skin Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Skin Cancer Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Skin Cancer Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Skin Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Radiotherapy
1.4.4 Cryosurgery
1.4.5 Immune Therapy
1.4.6 Photodynamic Therapy
1.4.7 Surgery
1.4.8 Other Treatments
1.5 Market by Application
1.5.1 Global Skin Cancer Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Cancer Research Center
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Skin Cancer Therapeutics Market Size
2.2 Skin Cancer Therapeutics Growth Trends by Regions
2.2.1 Skin Cancer Therapeutics Market Size by Regions (2014-2025)
2.2.2 Skin Cancer Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Skin Cancer Therapeutics Market Size by Manufacturers
3.1.1 Global Skin Cancer Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Skin Cancer Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Skin Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Skin Cancer Therapeutics Key Players Head office and Area Served
3.3 Key Players Skin Cancer Therapeutics Product/Solution/Service
3.4 Date of Enter into Skin Cancer Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Skin Cancer Therapeutics Market Size by Type (2014-2019)
4.2 Global Skin Cancer Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Skin Cancer Therapeutics Market Size (2014-2019)
5.2 Skin Cancer Therapeutics Key Players in United States
5.3 United States Skin Cancer Therapeutics Market Size by Type
5.4 United States Skin Cancer Therapeutics Market Size by Application
6 Europe
6.1 Europe Skin Cancer Therapeutics Market Size (2014-2019)
6.2 Skin Cancer Therapeutics Key Players in Europe
6.3 Europe Skin Cancer Therapeutics Market Size by Type
6.4 Europe Skin Cancer Therapeutics Market Size by Application
7 China
7.1 China Skin Cancer Therapeutics Market Size (2014-2019)
7.2 Skin Cancer Therapeutics Key Players in China
7.3 China Skin Cancer Therapeutics Market Size by Type
7.4 China Skin Cancer Therapeutics Market Size by Application
8 Japan
8.1 Japan Skin Cancer Therapeutics Market Size (2014-2019)
8.2 Skin Cancer Therapeutics Key Players in Japan
8.3 Japan Skin Cancer Therapeutics Market Size by Type
8.4 Japan Skin Cancer Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Skin Cancer Therapeutics Market Size (2014-2019)
9.2 Skin Cancer Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Skin Cancer Therapeutics Market Size by Type
9.4 Southeast Asia Skin Cancer Therapeutics Market Size by Application
10 India
10.1 India Skin Cancer Therapeutics Market Size (2014-2019)
10.2 Skin Cancer Therapeutics Key Players in India
10.3 India Skin Cancer Therapeutics Market Size by Type
10.4 India Skin Cancer Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Skin Cancer Therapeutics Market Size (2014-2019)
11.2 Skin Cancer Therapeutics Key Players in Central & South America
11.3 Central & South America Skin Cancer Therapeutics Market Size by Type
11.4 Central & South America Skin Cancer Therapeutics Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Skin Cancer Therapeutics Introduction
12.1.4 Pfizer Revenue in Skin Cancer Therapeutics Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Merck
12.2.1 Merck Company Details
12.2.2 Company Description and Business Overview
12.2.3 Skin Cancer Therapeutics Introduction
12.2.4 Merck Revenue in Skin Cancer Therapeutics Business (2014-2019)
12.2.5 Merck Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Skin Cancer Therapeutics Introduction
12.3.4 Novartis Revenue in Skin Cancer Therapeutics Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Company Details
12.4.2 Company Description and Business Overview
12.4.3 Skin Cancer Therapeutics Introduction
12.4.4 GlaxoSmithKline Revenue in Skin Cancer Therapeutics Business (2014-2019)
12.4.5 GlaxoSmithKline Recent Development
12.5 Bristol Myers Squibb
12.5.1 Bristol Myers Squibb Company Details
12.5.2 Company Description and Business Overview
12.5.3 Skin Cancer Therapeutics Introduction
12.5.4 Bristol Myers Squibb Revenue in Skin Cancer Therapeutics Business (2014-2019)
12.5.5 Bristol Myers Squibb Recent Development
12.6 Eli Lilly
12.6.1 Eli Lilly Company Details
12.6.2 Company Description and Business Overview
12.6.3 Skin Cancer Therapeutics Introduction
12.6.4 Eli Lilly Revenue in Skin Cancer Therapeutics Business (2014-2019)
12.6.5 Eli Lilly Recent Development
12.7 Roche
12.7.1 Roche Company Details
12.7.2 Company Description and Business Overview
12.7.3 Skin Cancer Therapeutics Introduction
12.7.4 Roche Revenue in Skin Cancer Therapeutics Business (2014-2019)
12.7.5 Roche Recent Development
12.8 Qiagen
12.8.1 Qiagen Company Details
12.8.2 Company Description and Business Overview
12.8.3 Skin Cancer Therapeutics Introduction
12.8.4 Qiagen Revenue in Skin Cancer Therapeutics Business (2014-2019)
12.8.5 Qiagen Recent Development
12.9 Boehringer Ingelheim
12.9.1 Boehringer Ingelheim Company Details
12.9.2 Company Description and Business Overview
12.9.3 Skin Cancer Therapeutics Introduction
12.9.4 Boehringer Ingelheim Revenue in Skin Cancer Therapeutics Business (2014-2019)
12.9.5 Boehringer Ingelheim Recent Development
12.10 Aqua Pharmaceuticals
12.10.1 Aqua Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Skin Cancer Therapeutics Introduction
12.10.4 Aqua Pharmaceuticals Revenue in Skin Cancer Therapeutics Business (2014-2019)
12.10.5 Aqua Pharmaceuticals Recent Development
12.11 Meda
12.12 Elekta AB
12.13 Varian Medical Systems
12.14 Valeant Pharmaceuticals
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Skin Cancer Therapeutics Key Market Segments
Table Key Players Skin Cancer Therapeutics Covered
Table Global Skin Cancer Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Skin Cancer Therapeutics Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Radiotherapy Figures
Table Key Players of Radiotherapy
Figure Cryosurgery Figures
Table Key Players of Cryosurgery
Figure Immune Therapy Figures
Table Key Players of Immune Therapy
Figure Photodynamic Therapy Figures
Table Key Players of Photodynamic Therapy
Figure Surgery Figures
Table Key Players of Surgery
Figure Other Treatments Figures
Table Key Players of Other Treatments
Table Global Skin Cancer Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Cancer Research Center Case Studies
Figure Others Case Studies
Figure Skin Cancer Therapeutics Report Years Considered
Table Global Skin Cancer Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Skin Cancer Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Skin Cancer Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Skin Cancer Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Skin Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Skin Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Skin Cancer Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Skin Cancer Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Skin Cancer Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Skin Cancer Therapeutics Market Share by Manufacturers in 2018
Table Global Skin Cancer Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Skin Cancer Therapeutics Product/Solution/Service
Table Date of Enter into Skin Cancer Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Skin Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Skin Cancer Therapeutics Market Size Share by Type (2014-2019)
Figure Global Skin Cancer Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Skin Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Skin Cancer Therapeutics Market Size Share by Application (2014-2019)
Figure Global Skin Cancer Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Skin Cancer Therapeutics Revenue Market Share by Application in 2018
Figure United States Skin Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Skin Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Skin Cancer Therapeutics Market Share (2018-2019)
Table United States Skin Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Skin Cancer Therapeutics Market Share by Type (2014-2019)
Table United States Skin Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Skin Cancer Therapeutics Market Share by Application (2014-2019)
Figure Europe Skin Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Skin Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Skin Cancer Therapeutics Market Share (2018-2019)
Table Europe Skin Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Skin Cancer Therapeutics Market Share by Type (2014-2019)
Table Europe Skin Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Skin Cancer Therapeutics Market Share by Application (2014-2019)
Figure China Skin Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Skin Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Skin Cancer Therapeutics Market Share (2018-2019)
Table China Skin Cancer Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Skin Cancer Therapeutics Market Share by Type (2014-2019)
Table China Skin Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Skin Cancer Therapeutics Market Share by Application (2014-2019)
Figure Japan Skin Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Skin Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Skin Cancer Therapeutics Market Share (2018-2019)
Table Japan Skin Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Skin Cancer Therapeutics Market Share by Type (2014-2019)
Table Japan Skin Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Skin Cancer Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Skin Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Skin Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Skin Cancer Therapeutics Market Share (2018-2019)
Table Southeast Asia Skin Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Skin Cancer Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Skin Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Skin Cancer Therapeutics Market Share by Application (2014-2019)
Figure India Skin Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Skin Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Skin Cancer Therapeutics Market Share (2018-2019)
Table India Skin Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Skin Cancer Therapeutics Market Share by Type (2014-2019)
Table India Skin Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Skin Cancer Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Skin Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Skin Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Skin Cancer Therapeutics Market Share (2018-2019)
Table Central & South America Skin Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Skin Cancer Therapeutics Market Share by Type (2014-2019)
Table Central & South America Skin Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Skin Cancer Therapeutics Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Skin Cancer Therapeutics Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Skin Cancer Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Merck Company Details
Table Merck Revenue in Skin Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Skin Cancer Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Skin Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Skin Cancer Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Skin Cancer Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Skin Cancer Therapeutics Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Bristol Myers Squibb Company Details
Table Bristol Myers Squibb Revenue in Skin Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Bristol Myers Squibb Revenue Growth Rate in Skin Cancer Therapeutics Business (2014-2019)
Table Bristol Myers Squibb Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Skin Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Skin Cancer Therapeutics Business (2014-2019)
Table Eli Lilly Recent Development
Table Roche Company Details
Table Roche Revenue in Skin Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Skin Cancer Therapeutics Business (2014-2019)
Table Roche Recent Development
Table Qiagen Company Details
Table Qiagen Revenue in Skin Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Qiagen Revenue Growth Rate in Skin Cancer Therapeutics Business (2014-2019)
Table Qiagen Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Skin Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Skin Cancer Therapeutics Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Aqua Pharmaceuticals Company Details
Table Aqua Pharmaceuticals Revenue in Skin Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Aqua Pharmaceuticals Revenue Growth Rate in Skin Cancer Therapeutics Business (2014-2019)
Table Aqua Pharmaceuticals Recent Development
Table Meda Company Details
Table Elekta AB Company Details
Table Varian Medical Systems Company Details
Table Valeant Pharmaceuticals Company Details
Table Global Skin Cancer Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Skin Cancer Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Skin Cancer Therapeutics Market Size Share by Regions in 2025
Figure United States Skin Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Skin Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Skin Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Skin Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Skin Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Skin Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Skin Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Skin Cancer Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Skin Cancer Therapeutics Market Size by Product (2019-2025)
Figure Global Skin Cancer Therapeutics Market Size by Product in 2025
Table Global Skin Cancer Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Skin Cancer Therapeutics Market Size by Application (2019-2025)
Figure Global Skin Cancer Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
皮膚がん治療薬の世界市場：市場規模・現状・予測 On the basis of the type of tissue affected, there are three major types of skin cancer, namely, basal cell carcinoma, squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the exte…- 非黒色腫皮膚癌の世界市場：市場規模・現状・予測 Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts.Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlikel…
- 卵巣癌遺伝子治療の世界市場：市場規模・現状・予測 Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- がん治療・バイオ治療の世界市場：市場規模・現状・予測 The global cancer therapeutics and biotherapeutics market is drived by the introduction of products such as gemcitabin, oxaliplatin and pemetrexed.The increasing occurrence of different types of cancer and the increasing proliferation of new players in this market are expected to boost the developme…
- がん遺伝子治療の世界市場：市場規模・現状・予測 Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has be…